Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
Taiko Pharmaceutical Dividend Announcement
• Taiko Pharmaceutical announced a quarterly dividend of ¥13.00 per ordinary share which will be made payable on . Ex dividend date: 2021-12-29
• Taiko Pharmaceutical's trailing twelve-month (TTM) dividend yield is -%
Taiko Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2021-12-29 | ¥13.00 | quarterly | |
2021-06-29 | ¥7.00 | quarterly | |
2020-12-29 | ¥8.00 | quarterly | 2021-03-31 |
2020-09-29 | ¥7.00 | quarterly | 2020-12-14 |
2020-03-30 | ¥10.00 | quarterly | 2020-06-29 |
2019-09-27 | ¥10.00 | quarterly | 2019-12-13 |
2019-03-27 | ¥10.00 | quarterly | 2019-06-28 |
2018-09-26 | ¥10.00 | quarterly | 2018-12-14 |
2018-03-28 | ¥10.00 | quarterly | 2018-06-29 |
2017-03-29 | ¥5.00 | quarterly | 2017-06-30 |
2016-03-29 | ¥15.00 | quarterly | |
2015-03-27 | ¥10.00 | quarterly | |
2014-03-27 | ¥10.00 | quarterly | |
2013-03-27 | ¥5.00 | quarterly | |
2012-03-28 | ¥5.00 | quarterly | |
2011-03-29 | ¥5.00 | quarterly | |
2010-03-29 | ¥5.00 | quarterly |
Taiko Pharmaceutical Dividend per year
Taiko Pharmaceutical Dividend growth
Taiko Pharmaceutical Dividend Yield
Taiko Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Taiko Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Taiko Pharmaceutical Financial Ratios
Taiko Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Taiko Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Taiko Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Taiko Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Taiko Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Taiko Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Taiko Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Taiko Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Taiko Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Taiko Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Taiko Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Taiko Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.